Standout Papers

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomi... 2022 2026 2023 2024122
  1. Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers (2022)
    Caroline Holm Nørgaard, Sarah Friedrich et al. Alzheimer s & Dementia Translational Research & Clinical Interventions

Immediate Impact

2 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
2024 Standout
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
2024 Standout
1 intermediate paper

Works of Ellen Holm being referenced

Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers
2022 Standout

Author Peers

Author Last Decade Papers Cites
Ellen Holm 110 125 83 224 188 57 1.1k
B. Filipiak 7 88 88 290 202 26 953
Lynda Wilton 159 103 99 28 139 49 1.3k
Jeremy Roberts 8 91 279 106 583 20 1.1k
Sang‐Ha Kim 17 47 381 62 279 117 1.2k
Joan Reisch 15 28 96 48 275 29 1.1k
Chiara Mameli 13 69 44 31 144 74 1.2k
R Moulias 39 60 66 22 281 101 1.1k
L. Hanssens 5 32 285 58 242 63 1.1k
Carla Carnovale 72 110 77 23 100 100 1.4k
Bing Zhou 27 11 56 69 292 57 1.1k

All Works

Loading papers...

Rankless by CCL
2026